Chapter 3: Pharmacology and Clinical Development of New Molecularly Targeted Agents Elisa Giovannetti, Elena Galvani
Chapter 4: Biomarkers as Prognostic, Predictive and Surrogate Endpoints Francesco Passiglia, Giuseppe Cicero, Marta Castiglia, and Viviana Bazan
Chapter 5: Evaluation of Response in Malignant Tumors Treated with Targeted Agents Giuseppe Lo Re, Federica Vernuccio, Maria Cristina Galfano, Federico Midiri, and Massimo Midiri
Chapter 6: Targeted Therapies for HER2-Positive Breast Cancer Maria Vittoria Dieci, Valentina Guarneri, Carlo Alberto Giorgi, and Pierfranco Conte
Chapter 7: Role of PARP Inhibitors in Triple Negative Breast Cancer (TNBC) Enrico Ricevuto, Katia Cannita, Gemma Bruera, Eleonora Palluzzi, Valentina Cocciolone, Corrado Ficorella, and Antonio Russo
Chapter 8: Targeted Therapies in Squamous Cell Carcinoma of the Head and Neck Pol Specenier
Chapter 9: Targeted Therapies for NSCLC Antonio Russo, Christian Rolfo, Francesco Passiglia, and Rafael Rosell
Chapter 10: Targeted Therapies for Gastric Cancer Nishi Kothari, Khaldoun Almhanna
Chapter 11: Targeted Therapies for Pancreatic Cancer León Mateos L, Grande Pulido E., and Antón Aparicio L.
Chapter 12: Targeted Therapies in Hepatocellular Carcinoma Fabrizio Bronte, Enrico Bronte, Giuseppe Bronte, and Vito Di Marco
Chapter 13: Targeted Therapies for Colorectal Cancer Antonio Russo, Antonio Galvano, Giuseppe Bronte, and Marc Peeters
Chapter 14: Targeted Therapy in Gastrointestinal Stromal Tumors Piotr Rutkowski, Joanna Przybyl, Agnieszka Wozniak, and Giuseppe Badalamenti
Chapter 15: Targeted Therapies in Kidney Cancer Amparo Sánchez Gastaldo, Aránzazu González del Alba, and Ignacio Durán
Chapter 16: Targeted Therapies in Melanoma Daniele Fanale, Giuseppe Bronte, and Antonio Russo
Chapter 17: Targeted Therapies for Prostate Cancer Aránzazu González del Alba, Luis León; Cristina Suárez, and Maria José Méndez
Chapter 18: Targeted Therapies for Bone Metastases Daniele Santini, Chiara Spoto, Vito Longo, Michele Iuliani, Alice Zoccoli, Salvatore Intagliata, Francesco Pantano, and Franco Silvestris
Antonio Russo, MD, PhD University of Palermo, Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, Palermo, Italy
Rafael Rosell, MD, PhD Hospital Germans Trias i Pujol, Catalan Institute of Oncology, Director, Cancer Biology & Precision Medicine Program, Badalona, Barcelona, Spain
Christian Rolfo, MD, PhD Antwerp University Hospital, Phase I - Early Clinical Trials Unit, Oncology Department and Multidisciplinary Oncology Center Antwerp, Edegem, Antwerpen, Belgium
This volume provides readers a comprehensive and state-of-the-art overview about the range of applications of targeted therapies for solid tumors. The sections of the book have been structured to review the oncogene addicted tumors, the pharmacology and clinical development of new molecularly targeted agents, the use of biomarkers as prognostic, predictive and surrogate endpoints, and the evaluation of tumor response and specific malignancies treated with targeted agents. The book also covers some of the newest developments in cancer therapy that are not adequately covered by any current available literature.
Written by recognized experts in the field, Targeted Therapies for Solid Tumors: A Handbook for Moving Toward New Frontiers in Cancer Treatment provides a unique and valuable resource in the field of molecular oncology, both for those currently in training, and for those already in clinical or research practice.